Buffered Magnesium.

Both the liver 25-hydroxylase and the kidney 1-alpha-hydroxylase that activate vitamin D are magnesium-dependent, as is the binding protein that carries it. Low magnesium blunts the conversion of a vitamin D dose into its active form.

Magnesium is required for Na/K-ATPase activity and it gates the renal outer medullary potassium channel, so potassium retention depends on magnesium status. Potassium repletion without magnesium tends not to hold.

Pyridoxal kinase uses magnesium-bound ATP as its substrate, so the two act on the same phosphorylation chemistry. That is the basis for their long-standing co-formulation.

Thiamine pyrophosphokinase needs magnesium to make thiamine pyrophosphate, and the TPP-dependent dehydrogenase complexes are magnesium-dependent too. Thiamine cannot function as a coenzyme without magnesium present.

Calcium and magnesium share paracellular and transcellular absorption routes, so large single doses of one reduce uptake of the other. They also act in opposition at the cell level, calcium driving contraction and magnesium acting as its counterweight.

High-dose zinc has been shown to reduce magnesium balance, and both are divalent cations competing for shared intestinal transport. Splitting the doses avoids the interference.

Buffered alkaline magnesium salts raise gastric pH, and non-heme iron needs an acidic stomach to stay soluble and reduced for uptake. Taking them together lowers iron absorption, so separate them by a couple of hours.

Betaine hydrochloride is taken to lower gastric pH while a buffered magnesium raises it, so the two work against each other in the same dose window. This is a timing conflict rather than a chemical incompatibility.

Creatine phosphate regenerates ATP, and ATP is biologically active as a magnesium complex in every kinase reaction that uses it. Magnesium is the cation that makes the phosphate transfer creatine supports possible.

Magnesium enables vitamin D activation and vitamin K2 carboxylates the proteins that direct where calcium is laid down. The three are formulated as a set because each covers a different step of mineral handling.

Boron intake has been associated with lower urinary excretion of magnesium and calcium in balance studies. That retention effect is why boron appears in magnesium and bone-mineral formulas.

Buffered magnesium products are frequently a chelate blended with magnesium oxide, and glycine is the most common chelating amino acid. Chelation keeps magnesium in a neutral complex rather than as a free divalent ion in the gut lumen. Whether that changes the amount absorbed is a separate question from the chemistry itself.

Taurine and magnesium are both concentrated inside cells and both influence membrane excitability, which is why the two are routinely formulated together. The pairing rests on shared physiology rather than on a combination trial. Regard it as mechanistic rather than measured.

Theanine acts on glutamatergic and GABAergic signalling while magnesium modulates NMDA receptor gating at the magnesium block. The mechanisms are distinct and are combined for that reason. There is no combination trial grounding this row, so it stands on the biochemistry of each part.

Melatonin acts through MT1 and MT2 receptors on circadian timing while magnesium works at ion channels and NMDA receptor gating. Combining them stacks two unrelated routes to the same positioning. Anyone already taking a sedating agent should count the additive effect.

Fermentation of inulin in the colon lowers luminal pH and generates short-chain fatty acids, conditions that keep magnesium in solution and increase paracellular uptake in the large bowel. This route matters most for the fraction of magnesium not absorbed higher up. The effect is measured on absorption markers rather than on clinical endpoints.

Short-chain fructans ferment faster and more proximally than long-chain inulin, acidifying the caecal contents where unabsorbed magnesium arrives. Lower pH keeps the ion soluble and available for paracellular transport. The trade-off is that faster fermentation is also what produces gas in sensitive people.

Buffered magnesium formats already carry alkaline magnesium oxide, hydroxide or carbonate, and adding bicarbonate stacks a second alkalinising agent in the same stomach. That raises gastric pH further, which changes how much of any acid-dependent ingredient in the same serving dissolves. Space them if a formula depends on gastric acidity.

Neutralising ascorbic acid with magnesium carbonate or hydroxide yields magnesium ascorbate, a non-acidic salt that supplies both. The buffering is the point: it removes the free acid that some people find irritating. The result is that magnesium dose and vitamin C dose become locked to each other.

Converting riboflavin to FMN and then FAD needs ATP, and the true substrate of a kinase is the magnesium-ATP complex rather than free ATP. Magnesium is therefore an obligatory participant in activating the vitamin. This is textbook cofactor chemistry, not a supplement study result.

In a zebrafish embryo model, magnesium and folate together lessened developmental abnormalities caused by an antiretroviral compound, with the authors framing magnesium chelation and folate one-carbon supply as the routes involved. This is a non-human developmental model and does not carry to human dosing. It is grounds for a mechanism, not for an effect.

Work optimising magnesium uptake in Lacticaseibacillus rhamnosus shows that lactic acid bacteria accumulate the mineral, which is the basis of mineral-enriched biomass ingredients. This was measured in culture, not in a person. It says something about the organism, not about what a co-taken dose does in the gut.

Manganese and magnesium both move through divalent metal transport routes and both occupy divalent binding sites on ATP and on metalloenzymes. A large single dose of one is the situation in which competition shows up, not a nutritional intake of each. Separating large doses is the practical answer.

Calcium and magnesium share paracellular and transcellular routes across the intestine, so large simultaneous doses compete. Calcium carbonate also adds its own alkalinity to an already buffered magnesium format. Splitting the two across the day removes both issues.

Phosphate and magnesium form sparingly soluble magnesium phosphate at intestinal pH, which lowers the fraction of either that stays in solution. High-phosphate meals and phosphate-salt supplements are the relevant exposures. Timing them apart is the standard answer.